Product image of Melperon (Melperone Hydrochloride) supplied by GNH India

Melperon

Active Ingredient:
Melperone Hydrochloride
Origin:
EU

Melperon (Melperone Hydrochloride)

Melperone Hydrochloride, the active ingredient in Melperon, is a typical antipsychotic presented as an oral dosage form for oral use. It is employed in the management of schizophrenia and other psychotic disorders in adult patients.
GNH India supplies Melperon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Melperon is a typical antipsychotic that acts on dopaminergic pathways to control psychotic symptoms.

  • Schizophrenia: reduces hallucinations, delusions and thought disorder.
  • Acute psychotic episodes: stabilises mood and diminishes severe agitation.
  • Chronic psychotic disorders: helps maintain long‑term symptom control.

How It Works

  • Melperone Hydrochloride exerts its antipsychotic effect primarily by antagonising dopamine D2 receptors in the mesolimbic and mesocortical pathways. This blockade diminishes dopaminergic neurotransmission that underlies psychotic symptoms, while also exhibiting moderate antagonism at serotonin 5‑HT2 receptors, contributing to its overall therapeutic profile.

Side Effects

Melperon may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Sedation: feeling unusually drowsy or sleepy.
  • Extrapyramidal symptoms: muscle stiffness, tremor or restlessness.
  • Weight gain: increase in body weight over time.
  • Dry mouth: reduced salivation leading to discomfort.
  • Constipation: slowed bowel movements.
  • Orthostatic hypotension: dizziness upon standing.

Serious or Rare Side Effects

  • Neuroleptic malignant syndrome: life‑threatening fever and muscle rigidity.
  • Tardive dyskinesia: persistent involuntary facial movements.
  • Agranulocytosis: severe reduction in white blood cells.
  • Seizures: risk of convulsive episodes.
  • Severe hypotension: marked drop in blood pressure.
  • Cardiac arrhythmia: irregular heart rhythm.

Precautions & Warnings

When prescribing Melperon, clinicians should consider several safety measures.

  • Monitor extrapyramidal symptoms: assess for rigidity, tremor or abnormal movements.
  • Assess cardiovascular status: watch for hypotension and arrhythmias.
  • Use caution in elderly patients: increased sensitivity to sedation and falls.
  • Avoid abrupt discontinuation: taper dose to reduce withdrawal effects.
  • Evaluate hepatic and renal function: adjust use if organ impairment is present.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Melperon can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • CNS depressants (e.g., benzodiazepines, opioids): may cause excessive sedation or respiratory depression.
  • Antihypertensives: additive hypotensive effect.
  • Drugs that prolong QT interval: increased risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may worsen dry mouth and constipation.
  • CYP2D6 inhibitors (e.g., fluoxetine): can raise melperon plasma levels.
  • Antipsychotic polytherapy: heightened risk of extrapyramidal symptoms and metabolic effects.

Frequently Asked Questions

Melperon is indicated for the treatment of schizophrenia and other psychotic disorders. It helps control symptoms such as hallucinations, delusions, and thought disturbances by modulating dopamine activity in the brain.

Melperone hydrochloride works mainly by blocking dopamine D2 receptors, which reduces excessive dopaminergic signaling that contributes to psychotic symptoms. It also has moderate activity at serotonin receptors, adding to its antipsychotic effect.

The appropriate dose of Melperon is determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions.

Safety data for melperone in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and consider alternative treatments when appropriate. Women should discuss any concerns with their physician.

To request Melperon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melperon belongs to the butyrophenone class of typical antipsychotics, similar to haloperidol. It shares a dopamine D2 antagonism profile but may differ in side‑effect frequency, such as a potentially lower incidence of extrapyramidal symptoms, though individual responses vary.

Melperon should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Melperon is administered orally, typically as a tablet taken with water. The exact dosing schedule and whether it should be taken with food are determined by the prescriber based on the patient’s therapeutic needs.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, agranulocytosis, severe hypotension, and cardiac arrhythmias. Patients should be monitored regularly for early signs of these conditions, and any concerning symptoms should prompt immediate medical evaluation.

Melperon is contraindicated in patients with known hypersensitivity to melperone or any component of the formulation. Caution is advised for individuals with severe central nervous system depression, uncontrolled cardiovascular disease, or a history of neuroleptic malignant syndrome.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Melperone Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT